This P-RCE brings together the strengths of 77 researchers, both basic and clinical and from both Universities and Industry, in the states of Minnesota, Illinois, Michigan, Indiana, and Ohio. Administrative infrastructure for this application includes leadership at each one of the institutions involved. Our research strengths are in Basic Biology of Category A agents of Bioterrorism, Inhalation Biology and Host Response to Category A organisms, Diagnostics and Experimental Therapeutics, and Vaccine Evaluation, the latter where we have two premier organizations committed to participate. We are particularly interested in moving basic research into clinical application. We submit two R01s and several concept projects in these areas. The first R01 seeks funding to study a novel two-component regulatory system in Bacillus anthracis that in other Gram-positive bacteria is essential to virulence. We have shown that the regulatory system homologue exists in B. anthracis and have initiated studies to clone and insertionally inactivate the system. Furthermore, we hypothesize that this regulatory system is the target of compounds that we have identified and inhibit production of exotoxins. The second R01 provides an example of our strength in Inhalation Biology with a project to study the mechanism underlying Francisella tularensis entry and trafficking into macrophages, and the role surfactant plays in these processes. Concept projects complement these studies and initiate research into Category A viral agents. We anticipate that in 1-2 years these grants will develop into 3-4 program projects. In addition, we have assembled a team of highly-skilled leaders to train both present and future researchers in the safe handling of Category A agents; we have a large collective number of BSL3 facilities to achieve this training, combined with a well-conceived plan. Finally, we have begun development of seamless interactions with first-line emergency responders in all Region V states, with our intent to serve as overflow """"""""Bench Workers"""""""" if bioterrorism events occur.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory Grants--Cooperative Agreements (U56)
Project #
1U56AI057164-01
Application #
6698883
Study Section
Special Emphasis Panel (ZAI1-AC-M (M1))
Program Officer
Garges, Susan
Project Start
2003-09-04
Project End
2005-08-31
Budget Start
2003-09-04
Budget End
2004-08-31
Support Year
1
Fiscal Year
2003
Total Cost
$683,088
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Gavrilin, Mikhail A; Mitra, Srabani; Seshadri, Sudarshan et al. (2009) Pyrin critical to macrophage IL-1beta response to Francisella challenge. J Immunol 182:7982-9
Premanandan, Christopher; Storozuk, Craig A; Clay, Corey D et al. (2009) Complement protein C3 binding to Bacillus anthracis spores enhances phagocytosis by human macrophages. Microb Pathog 46:306-14
Bhargava, Maneesh; Runyon, Marie R; Smirnov, Dmitri et al. (2008) Triiodo-L-thyronine rapidly stimulates alveolar fluid clearance in normal and hyperoxia-injured lungs. Am J Respir Crit Care Med 178:506-12
Mohapatra, Nrusingh P; Balagopal, Ashwin; Soni, Shilpa et al. (2007) AcpA is a Francisella acid phosphatase that affects intramacrophage survival and virulence. Infect Immun 75:390-6
Vetter, Sara M; Schlievert, Patrick M (2007) The two-component system Bacillus respiratory response A and B (BrrA-BrrB) is a virulence factor regulator in Bacillus anthracis. Biochemistry 46:7343-52
Premanandan, Christopher; Lairmore, Michael D; Fernandez, Soledad et al. (2006) Quantitative measurement of anthrax toxin receptor messenger RNA in primary mononuclear phagocytes. Microb Pathog 41:193-8
Krathwohl, Mitchell D; Anderson, Jodi L (2006) Chemokine CXCL10 (IP-10) is sufficient to trigger an immune response to injected antigens in a mouse model. Vaccine 24:2987-93
Balagopal, Ashwin; MacFarlane, Amanda Shearer; Mohapatra, Nrusingh et al. (2006) Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun 74:5114-25
Huang, K J; Wooley, D P (2005) A new cell-based assay for measuring the forward mutation rate of HIV-1. J Virol Methods 124:95-104
Vetter, Sara M; Schlievert, Patrick M (2005) Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis. Antimicrob Agents Chemother 49:1302-5